1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. US Lymphedema Treatment Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. US Lymphedema Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. US Lymphedema Treatment Market Regional Analysis
6.2 US Lymphedema Treatment Market Revenue 2020-2028 (US$ Million)
6.3 US Lymphedema Treatment Market Forecast Analysis
7. US Lymphedema Treatment Market Analysis – by Condition Type
7.1 Primary Lymphedema
- 7.1.1 Overview
- 7.1.2 Primary Lymphedema: US Lymphedema Treatment Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Secondary Lymphedema
- 7.2.1 Overview
- 7.2.2 Secondary Lymphedema: US Lymphedema Treatment Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. US Lymphedema Treatment Market Analysis – by Treatment Type
8.1 Laser Therapy
- 8.1.1 Overview
- 8.1.2 Laser Therapy: US Lymphedema Treatment Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Compression Devices & Bandaging
- 8.2.1 Overview
- 8.2.2 Compression Devices & Bandaging: US Lymphedema Treatment Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.3 Drug Therapy
- 8.3.1 Overview
- 8.3.2 Drug Therapy: US Lymphedema Treatment Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.4 Physiological Procedures
- 8.4.1 Overview
- 8.4.2 Physiological Procedures: US Lymphedema Treatment Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.5 Debulking Procedures
- 8.5.1 Overview
- 8.5.2 Debulking Procedures: US Lymphedema Treatment Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. US Lymphedema Treatment Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: US Lymphedema Treatment Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Clinics
- 9.2.1 Overview
- 9.2.2 Clinics: US Lymphedema Treatment Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.3 Clinical Research Organization
- 9.3.1 Overview
- 9.3.2 Clinical Research Organization: US Lymphedema Treatment Market – Revenue and Forecast, 2020-2028 (US$ Million)
10. US Lymphedema Treatment Market – United States Analysis
10.1 Overview
10.2 United States
- 10.2.1 US Lymphedema Treatment Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 10.2.1.1 US Lymphedema Treatment Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 United States :
US Lymphedema Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 United States : US Lymphedema Treatment Market Breakdown, by Condition Type
- 10.2.1.1.2 United States : US Lymphedema Treatment Market Breakdown, by Treatment Type
- 10.2.1.1.3 United States : US Lymphedema Treatment Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 BIOCOMPRESSION SYSTEMS
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Tactile Medical
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Smith & Nephew
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Essity AB
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Lohmann & Rauscher GmbH & Co. KG
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 SIGVARIS GROUP
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 ThermoTek
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Huntleigh Healthcare Limited
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 3M
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Airos Medical, Paul Hartmann AG
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For US Lymphedema Treatment Market
